Prudential Financial’s Rhythm Pharmaceuticals RYTM Stock Holding History

Prudential Financial’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.63M	Sell	30,190 -22,955	-43%	-$2.23M	﹤0.01%	1203
2025 Q4	$5.69M	Sell	53,145 -19,865	-27%	-$2.11M	0.01%	856
2025 Q3	$7.37M	Buy	73,010 +65,915	+929%	+$6.12M	0.01%	748
2025 Q2	$423K	Buy	7,095 +2,740	+63%	+$168K	﹤0.01%	1990
2025 Q1	$243K	Buy	4,355 +200	+5%	+$11.1K	﹤0.01%	2021
2024 Q4	$234K	Sell	4,155 -104	-2%	-$5.75K	﹤0.01%	2053
2024 Q3	$223K	Buy	+4,259	New	+$204K	﹤0.01%	2481
2022 Q1	–	Sell	-46,400	Closed	-$463K	–	2683
2021 Q4	$463K	Buy	46,400 +23,648	+104%	+$266K	﹤0.01%	2229
2021 Q3	$297K	Sell	22,752 -8,221	-27%	-$126K	﹤0.01%	2329
2021 Q2	$607K	Buy	+30,973	New	+$643K	﹤0.01%	2065

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Prudential Financial's RYTM Position: Q1 2026 in Review

Prudential Financial reduced its Rhythm Pharmaceuticals (RYTM) stake by 43% in Q1 2026, selling an estimated $2.23M and leaving 30,190 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1203.

Prudential Financial first reported a position in RYTM in Q2 2021 and has held it in 10 quarters since. The position peaked at $7.37M in Q3 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

Prudential Financial held 30,190 shares of Rhythm Pharmaceuticals worth $2.63M as of Q1 2026.
Prudential Financial sold 22,955 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $2.23M.
Rhythm Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1203 holding.
Prudential Financial first reported a position in Rhythm Pharmaceuticals in Q2 2021 and has held it in 10 quarters since.
Prudential Financial's Rhythm Pharmaceuticals position peaked at $7.37M in Q3 2025.
285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.